AI assistant
Sending…
Lunai Bioworks Inc. — Director's Dealing 2021
Nov 23, 2021
34813_dirs_2021-11-23_2fd0b6a4-93d7-4f09-a9ce-dbb2a3623815.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Enochian Biosciences Inc (ENOB)
CIK: 0001527728
Period of Report: 2021-10-26
Reporting Person: Puche Luisa (Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-10-26 | Option to purchase shares of common stock | $8.58 | A | 60000 | Acquired | 2031-10-26 | Common stock (60000) | Direct |
Footnotes
F1: The options vest ratably on October 26, 2022, October 26, 2023 and October 26, 2024.
More from Lunai Bioworks Inc.
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 1
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 13
Regulatory Filings
2026
Feb 23
Interim / Quarterly Report
2026
Feb 17
Regulatory Filings
2026
Feb 12